| scholarly article | Q13442814 |
| P356 | DOI | 10.1177/0961203312470186 |
| P698 | PubMed publication ID | 23257402 |
| P2093 | author name string | F Wolfe | |
| K Michaud | |||
| R Katz | |||
| E F Chakravarty | |||
| P2860 | cites work | Therapy of lupus nephritis: lessons learned from clinical research and daily care of patients | Q36084894 |
| Herpes zoster in juvenile-onset systemic lupus erythematosus: incidence, clinical characteristics and risk factors. | Q36549594 | ||
| Herpes zoster risk factors in a national cohort of veterans with rheumatoid arthritis | Q37346732 | ||
| Mycophenolate mofetil in the treatment of systemic lupus erythematosus | Q37896445 | ||
| Incidence, risk factors, and outcome of Herpes zoster in systemic lupus erythematosus. | Q43136406 | ||
| Normative values for the Health Assessment Questionnaire disability index: benchmarking disability in the general population | Q44366478 | ||
| Herpes zoster vaccination among adults aged 60 years and older, in the U.S., 2008. | Q45562669 | ||
| A Population-Based Study of the Incidence and Complication Rates of Herpes Zoster Before Zoster Vaccine Introduction | Q28112193 | ||
| A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults | Q28254168 | ||
| The National Data Bank for rheumatic diseases: a multi-registry rheumatic disease data bank | Q33452656 | ||
| Varicella-zoster virus-specific immune responses in elderly recipients of a herpes zoster vaccine | Q33585349 | ||
| Herpes zoster incidence among insured persons in the United States, 1993-2006: evaluation of impact of varicella vaccination | Q34158156 | ||
| Risk of herpes zoster in patients with systemic lupus erythematosus: a three-year follow-up study using a nationwide population-based cohort | Q35141927 | ||
| Risk of Herpes zoster in patients with underlying diseases: a retrospective hospital-based cohort study | Q35556161 | ||
| P433 | issue | 3 | |
| P921 | main subject | systemic lupus erythematosus | Q1485 |
| herpes zoster | Q182155 | ||
| P304 | page(s) | 238-244 | |
| P577 | publication date | 2012-12-20 | |
| P1433 | published in | Lupus | Q6704846 |
| P1476 | title | Increased incidence of herpes zoster among patients with systemic lupus erythematosus. | |
| P478 | volume | 22 |
| Q39606086 | Adult asthma is associated with an increased risk of herpes zoster: A population-based cohort study. |
| Q40106216 | Advances in our understanding of immunization and vaccines for patients with systemic lupus erythematosus |
| Q40553708 | Comparative Rates of Serious Infections Among Patients With Systemic Lupus Erythematosus Receiving Immunosuppressive Medications. |
| Q24276383 | Developments in Varicella Zoster Virus Vasculopathy |
| Q54261998 | Fatal visceral disseminated varicella zoster infection during initial remission induction therapy in a patient with lupus nephritis and rheumatoid arthritis-possible association with mycophenolate mofetil and high-dose glucocorticoid therapy: a case |
| Q90697238 | From Severe Herpes Zoster to Rare Suid Herpesvirus Encephalitis: A New Twist of the Varicellovirus Genus Infection in Patients with Kidney Diseases |
| Q47139465 | Herpes zoster in patients with systemic lupus erythematosus: Clinical features, complications and risk factors |
| Q47548019 | Herpes zoster infection after topical steroid use in the setting of tumid lupus erythematosus |
| Q37402728 | Herpes zoster vaccination in SLE: a pilot study of immunogenicity |
| Q34376752 | Herpes zoster: diagnostic, therapeutic, and preventive approaches |
| Q36916866 | Infections and systemic lupus erythematosus |
| Q38182646 | Interplay of infections, autoimmunity, and immunosuppression in systemic lupus erythematosus |
| Q97523147 | JAK inhibitors and infections risk: focus on herpes zoster |
| Q59349350 | Longitudinal analysis of varicella-zoster virus-specific antibodies in systemic lupus erythematosus: No association with subclinical viral reactivations or lupus disease activity |
| Q36099232 | Longitudinal risk of herpes zoster in patients with non-Hodgkin lymphoma receiving chemotherapy: A nationwide population-based study |
| Q35885259 | National Lupus Hospitalization Trends Reveal Rising Rates of Herpes Zoster and Declines in Pneumocystis Pneumonia |
| Q38779854 | Risk of Herpes Zoster in Autoimmune and Inflammatory Diseases: Implications for Vaccination |
| Q35655534 | Serious infections among adult Medicaid beneficiaries with systemic lupus erythematosus and lupus nephritis |
| Q37634514 | The case for Zostavax vaccination in systemic lupus erythematosus |
| Q58560058 | VZV-specific T-cell levels in patients with rheumatic diseases are reduced and differentially influenced by antirheumatic drugs |
| Q38285275 | Vaccination of patients with autoimmune inflammatory rheumatic diseases |
| Q37135056 | Vaccine-preventable infections in Systemic Lupus Erythematosus |
Search more.